Ardelyx (ARDX) Accumulated Depreciation & Amortization (2013 - 2025)
Ardelyx posted quarterly Accumulated Depreciation & Amortization of $3.1 million for Q4 2025, up 48.28% year-on-year from $2.1 million in Q4 2024, and up 48.28% on a QoQ basis from $2.1 million in Q4 2024.
Ardelyx (ARDX) has 13 years of Accumulated Depreciation & Amortization data on file, last reported at $3.1 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 48.28% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (up 48.28% YoY), and the FY2025 full-year result was $3.1 million, up 48.28% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $3.1 million, up from $2.1 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $3.1 million in Q4 2025 and bottomed at $1.1 million in Q4 2022.
- The 5-year median for Accumulated Depreciation & Amortization is $2.1 million (2024), against an average of $2.1 million.
- The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization slumped 59.24%; it then surged 59.67% in 2024.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $2.8 million in 2021, then plunged by 59.24% to $1.1 million in 2022, then advanced by 12.94% to $1.3 million in 2023, then soared by 59.67% to $2.1 million in 2024, then soared by 48.28% to $3.1 million in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $3.1 million (Q4 2025), $2.1 million (Q4 2024), and $1.3 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.06 Mn |
| Dec 31, 2025 | 3.06 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Dec 31, 2020 | 2.54 Mn |
| Dec 31, 2020 | 2.54 Mn |
| Dec 31, 2019 | 2.50 Mn |
| Dec 31, 2019 | 2.50 Mn |
| Dec 31, 2018 | 2.70 Mn |
| Dec 31, 2018 | 2.70 Mn |
| Dec 31, 2017 | 2.60 Mn |
| Dec 31, 2017 | 2.60 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Dec 31, 2015 | 800,000.00 |
| Dec 31, 2015 | 800,000.00 |
| Dec 31, 2014 | 300,000.00 |
| Dec 31, 2014 | 300,000.00 |
| Dec 31, 2013 | 600,000.00 |
| Dec 31, 2013 | 600,000.00 |